Skip to main content
. 2021 Jan 13;11:43. doi: 10.1038/s41398-020-01165-x

Table 2.

Service user characteristics.

Number of services (%)
Sociodemographic characteristics
 Sample size 33
 <50 12 (39.4)
 50–100 6 (18.2)
 >100 15 (45.5)
Sex 43 (CHR-P individuals)
 Male (frequency %) 57.2
CHR-P Assessment (not mutually exclusive) 37
 CAARMS 18 (48.6)
 SIPS 13 (35.1)
 ERIraos-CL 6 (16.2)
 BSIP 2 (5.4)
 BSABS/SPI-A/SPI-CY 1 (2.7)
Min. age inclusion criteria 48
 Between 8 and 6 years 2 (4.2)
 12 years 12 (25)
 Between 13 and 15 years 15 (31.3)
 Between 16 and 17 years 13 (27.1)
 18 years or older 6 (12.5)
Max. age inclusion criteria 49
 18 years 4 (8.2)
 Between 24 and 29 years 14 (28.6)
 Between 30 and 35 years 24 (49.0)
 Between 40 and 56 years 4 (8.2)
 65 years or older 3 (6.1)
Service users age range 51
 Children and adolescents only (<18) 2 (3.9)
 Adolescents only (12–18) 2 (3.9)
 Adolescents and young adults (12–35) 36 (70.6)
 Children, adolescents and adults (8–40) 1 (2.0)
 Adolescents and adults (≥12)a 5 (9.8)
 Young adults (18–35) 4 (7.8)
 Adults only (≥18) 1 (2.0)
CHR-P individuals (%)
Diagnostic subgroups (not mutually exclusive) 17b
 APS 82.6
 BLIPS 10.7
 GRD 8.5
Comorbidity (not mutually exclusive)c 31b
 Any DSM/ICD comorbid disorder 69.5
 Depressive disorders 42.3
 Bipolar disorder 15.5
 Persistent depressive disorder 6.7
 History of suicide attempts 10.5
 Anxiety disorders 24.1
 Social phobia 5.9
 Obsessive compulsive disorder 5.1
 Adjustment disorder 11.6
 Any personality disorder 15.5
 Schizotypal personality disorder 11.0
 Substance use disorders 12.4
Employment 13b
 Unemployment rates 36.6

aIncludes two services that enrolled “adolescents and adults” without further specification.

bNumber of services providing data for the service user characteristics as % CHR-P individuals.

cDiagnosis according to DSM or ICD criteria stablished using either structured interviews or clinical interviews.

APS attenuated psychosis symptoms, BLIPS brief limited intermittent psychotic symptoms, BSABS Bonn scale for the assessment of basic symptoms, BSIP Basel screening instrument for psychosis, CAARMS comprehensive assessment of at-risk mental states, ERIraos-CL early recognition inventory retrospective assessment of symptoms checklist, GRD genetic risk and deterioration, SIPS structured interview for psychosis-risk syndromes, SPI-A schizophrenia proneness instrument (adults version), SPI-CY schizophrenia proneness instrument (child and youth version).